Dr Tim Brettig
Dr Tim Brettig
Contact
Email
show email address
Dr Tim Brettig is a Paediatric Allergist and Immunologist, Post-doctoral fellow and senior study doctor with the Population Allergy group at the Murdoch Children’s Research Institute (MCRI). Tim is post-doc within the food allergy stream of the National Allergy Centre of Excellence (NACE), hosted by MCRI. He is also as a private consultant at a leading Melbourne allergy group (MACCS).
Tim’s research journey began in 2020, commencing his PhD with the population allergy group. In 2023, he completed his PhD with the University of Melbourne, titled “Exploring the investigation, diagnosis and clinical management of tree nut and peanut allergy”. This investigated the prevalence of cashew nut allergy, the evidence behind several diagnostic tests used in clinical food allergy assessment and explored novel approaches to diagnosis to provide both improved clinical outcome and reduced health costs.
Tim has experience in several research trials, encompassing prevention, treatment and epidemiology of food allergy. He is the sponsored trials team leader in population allergy, encompassing an increasing number of sponsored trials focussed on food allergy treatments.
He continues to combine his research work alongside his clinical role and is passionate to drive translation of research into clinical care. His current work involves food allergy treatments that are aimed to improve the lives of those living with food allergy.
Tim’s research journey began in 2020, commencing his PhD with the population allergy group. In 2023, he completed his PhD with the University of Melbourne, titled “Exploring the investigation, diagnosis and clinical management of tree nut and peanut allergy”. This investigated the prevalence of cashew nut allergy, the evidence behind several diagnostic tests used in clinical food allergy assessment and explored novel approaches to diagnosis to provide both improved clinical outcome and reduced health costs.
Tim has experience in several research trials, encompassing prevention, treatment and epidemiology of food allergy. He is the sponsored trials team leader in population allergy, encompassing an increasing number of sponsored trials focussed on food allergy treatments.
He continues to combine his research work alongside his clinical role and is passionate to drive translation of research into clinical care. His current work involves food allergy treatments that are aimed to improve the lives of those living with food allergy.
Dr Tim Brettig is a Paediatric Allergist and Immunologist, Post-doctoral fellow and senior study doctor with the Population Allergy group at the Murdoch Children’s Research Institute (MCRI). Tim is post-doc within the food allergy stream of the...
Dr Tim Brettig is a Paediatric Allergist and Immunologist, Post-doctoral fellow and senior study doctor with the Population Allergy group at the Murdoch Children’s Research Institute (MCRI). Tim is post-doc within the food allergy stream of the National Allergy Centre of Excellence (NACE), hosted by MCRI. He is also as a private consultant at a leading Melbourne allergy group (MACCS).
Tim’s research journey began in 2020, commencing his PhD with the population allergy group. In 2023, he completed his PhD with the University of Melbourne, titled “Exploring the investigation, diagnosis and clinical management of tree nut and peanut allergy”. This investigated the prevalence of cashew nut allergy, the evidence behind several diagnostic tests used in clinical food allergy assessment and explored novel approaches to diagnosis to provide both improved clinical outcome and reduced health costs.
Tim has experience in several research trials, encompassing prevention, treatment and epidemiology of food allergy. He is the sponsored trials team leader in population allergy, encompassing an increasing number of sponsored trials focussed on food allergy treatments.
He continues to combine his research work alongside his clinical role and is passionate to drive translation of research into clinical care. His current work involves food allergy treatments that are aimed to improve the lives of those living with food allergy.
Tim’s research journey began in 2020, commencing his PhD with the population allergy group. In 2023, he completed his PhD with the University of Melbourne, titled “Exploring the investigation, diagnosis and clinical management of tree nut and peanut allergy”. This investigated the prevalence of cashew nut allergy, the evidence behind several diagnostic tests used in clinical food allergy assessment and explored novel approaches to diagnosis to provide both improved clinical outcome and reduced health costs.
Tim has experience in several research trials, encompassing prevention, treatment and epidemiology of food allergy. He is the sponsored trials team leader in population allergy, encompassing an increasing number of sponsored trials focussed on food allergy treatments.
He continues to combine his research work alongside his clinical role and is passionate to drive translation of research into clinical care. His current work involves food allergy treatments that are aimed to improve the lives of those living with food allergy.
Top Publications
- Brettig, T, Dalziel, K, Koplin, J, Dang, T, Lange, L, William, VM, Sato, S, Savvatianos, S, Perrett, K. Ana o 3 sIgE and diagnostic algorithms reduce cost of cashew allergy diagnosis in children compared to skin prick test: a cost comparison analysis. 2024 view publication
- Brettig, T, Koplin, JJ, Dang, T, Lange, L, McWilliam, V, Sato, S, Savvatianos, S, Perrett, KP. Cashew allergy diagnosis: A two-step algorithm leads to fewer oral food challenges.. J Allergy Clin Immunol Pract 10(6) : 1652 -1654.e2 2022 view publication
- Brettig, T, Dalziel, K, Koplin, J, Perrett, K. Diagnostic Algorithms for Cashew Allergy in Children Reduce Oral Food Challenges and Overall Cost. Journal of Allergy and Clinical Immunology 149(2) : ab112 2022 view publication
- Arnold, DE, Nofal, R, Wakefield, C, Lehmberg, K, Wustrau, K, Albert, MH, Morris, EC, Heimall, JR, Bunin, NJ, Kumar, A, et al. Reduced-Intensity/Reduced-Toxicity Conditioning Approaches Are Tolerated in XIAP Deficiency but Patients Fare Poorly with Acute GVHD.. J Clin Immunol 42(1) : 36 -45 2022 view publication
- Dang, TD, Peters, R, Neeland, MR, Brettig, T, Green, H, McWilliam, V, Tang, MLK, Dharmage, S, Ponsonby, A-L, Koplin, J, et al. Ana o 3 sIgE testing increases the accuracy of cashew allergy diagnosis using a two-step model.. Pediatr Allergy Immunol 33(1) : e13705 2022 view publication
Page 1 of 2
Career information
Share //
